Rankings
▼
Calendar
PRAX Q3 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$302,000
-35.5% YoY
Gross Profit
-$42M
-13767.9% margin
Operating Income
-$57M
-18819.5% margin
Net Income
-$52M
-17188.7% margin
EPS (Diluted)
$-2.75
QoQ Revenue Growth
-15.4%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$28M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$416M
Total Liabilities
$34M
Stockholders' Equity
$383M
Cash & Equivalents
$169M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$302,000
$468,000
-35.5%
Gross Profit
-$42M
-$17M
-147.6%
Operating Income
-$57M
-$26M
-122.7%
Net Income
-$52M
-$25M
-110.7%
← FY 2024
All Quarters
Q4 2024 →